RIPC, using intermittent upper arm ischemia–reperfusion cycles, appears to confer protection against CIN in subjects with moderate renaldysfunction undergoing PCI. Larger studies are needed to investigateits potential effect on diabetic patients.
RIPC, using intermittent upper arm ischemia–reperfusion cycles, appears to confer protection against CIN in subjects with moderate renaldysfunction undergoing PCI. Larger studies are needed to investigateits potential effect on diabetic patients.<br>